Veraxa Biotech Ag (VRXA) Stock Price, Quote & News

Company Profile

VERAXA Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, with some in clinical development, and it provides partnership models for collaborative development from t...

Industry: Biotechnology

Sector: Healthcare

Phone: 49 6221 3521330

Website: www.veraxa.com

Address:

Im Neuenheimer Feld 584, Heidelberg, Germany

jearhart29 Aug. 12 at 2:48 PM

$VRXA any upcoming catalyst?

0 · Reply

NetworkNewsWire Aug. 7 at 5:47 PM

BioMedNewsBreaks — $VRXA Builds Strategic Position in Antibody Therapeutics Market https://ibn.fm/KQalK

1 · Reply

NetworkNewsWire Aug. 5 at 7:34 PM

$VRXA Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies https://ibn.fm/OP3FF

0 · Reply

jearhart29 Aug. 5 at 2:13 PM

$VRXA something brewing??

0 · Reply

NetworkNewsWire Jul. 29 at 7:48 PM

$VRXA Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC(R) Cancer Therapy Platform https://ibn.fm/V6K8z

0 · Reply

NetworkNewsWire Jul. 29 at 6:32 PM

InvestorNewsBreaks – $VRXA Expands Patent Portfolio to Support Next-Generation Cancer Therapy Platforms https://ibn.fm/b5YiO

0 · Reply

AndorianMoons Jul. 29 at 12:47 PM

$VRXA https://investors.veraxa.com/news-releases/news-release-details/veraxa-biotech-strengthens-patent-portfolio-protect-core

0 · Reply

topstockalerts Jul. 27 at 8:08 PM

$VRXA low key strong… might catch people off guard

0 · Reply

NetworkNewsWire Jul. 27 at 3:47 PM

MissionIRNewsBreaks – $VRXA Shareholders Approve Corporate Governance, Financing Measures https://ibn.fm/PDGbt

0 · Reply

NetworkNewsWire Jul. 27 at 3:32 PM

BioMedNewsBreaks — $VRXA Advances Bispecific ADC Program Under OmniAb Collaboration https://ibn.fm/qMRuJ

0 · Reply

VERAXA Biotech Strengthens Patent Portfolio to Protect Core Technology Platforms and Product Candidates

2026-07-27T11:20:47.000Z - 21 days ago

Veraxa Biotech advances VXA-222 following milestone in OmniAb pact

OABI

Jul 27, 2026, 7:00 AM EDT - 21 days ago

VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb

Jul 24, 2026, 4:05 PM EDT - 24 days ago

VERAXA Biotech Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Strategic Flexibility for Future Growth

2026-07-23T11:36:04.000Z - 25 days ago

Veraxa Biotech appoints Christoph Erkel as chief scientific officer

Jul 23, 2026, 7:00 AM EDT - 25 days ago

VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC® Technology Platforms and Portfolio

Jul 20, 2026, 7:00 AM EDT - 4 weeks ago

VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan

2026-07-13T11:25:51.000Z - 5 weeks ago

Veraxa Biotech announces BiTAC pipeline collaboration with Ardigen

Jul 13, 2026, 7:00 AM EDT - 5 weeks ago

VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC® Pipeline

2026-07-10T20:10:12.000Z - 5 weeks ago

Veraxa CFO Torsten Burgermeister steps down, Carl von Halem named interim CFO

Jul 10, 2026, 4:05 PM EDT - 5 weeks ago

VERAXA Biotech AG Appoints Carl von Halem as Interim Chief Financial Officer and Successor to Torsten Bürgermeister

2026-07-06T13:15:07.000Z - 6 weeks ago

Veraxa Biotech provides pipeline and partnering strategy update

Jul 6, 2026, 7:00 AM EDT - 6 weeks ago

VERAXA Biotech Provides Business Update and Further Details on Partnering Strategy and Development Timelines

2026-07-02T11:30:29.000Z - 6 weeks ago

Veraxa Biotech initiates cell line development for BiTAC T-cell engager program

Jul 2, 2026, 7:00 AM EDT - 6 weeks ago

VERAXA Biotech Initiates Cell Line Development with ATUM to Advance its Lead BiTAC®-TCE Program

2026-06-24T11:10:26.000Z - 7 weeks ago

Veraxa Biotech expands R&D site in Germany

Jun 24, 2026, 7:00 AM EDT - 7 weeks ago

VERAXA Biotech Expands R&D Hub in Heidelberg as Innovative BiTAC™-TCE and ADC Programs Advance Towards Clinical Development

2026-06-18T11:21:38.000Z - 2 months ago

Veraxa Biotech establishes in vitro proof-of-concept for BiTAC-ADC platform

Jun 18, 2026, 7:00 AM EDT - 2 months ago

VERAXA Biotech Establishes in vitro Proof-of-Concept for Novel BiTAC-ADC Technology Platform and Launches Partnering Discussions at BIO International Convention 2026

2026-06-16T15:10:31.000Z - 2 months ago

Veraxa Biotech AG trading resumes

2026-06-16T15:00:10.000Z - 2 months ago

Veraxa Biotech AG trading halted, volatility trading pause

jearhart29 Aug. 12 at 2:48 PM

$VRXA any upcoming catalyst?

0 · Reply

NetworkNewsWire Aug. 7 at 5:47 PM

BioMedNewsBreaks — $VRXA Builds Strategic Position in Antibody Therapeutics Market https://ibn.fm/KQalK

1 · Reply

NetworkNewsWire Aug. 5 at 7:34 PM

$VRXA Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies https://ibn.fm/OP3FF

0 · Reply

jearhart29 Aug. 5 at 2:13 PM

$VRXA something brewing??

0 · Reply

NetworkNewsWire Jul. 29 at 7:48 PM

$VRXA Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC(R) Cancer Therapy Platform https://ibn.fm/V6K8z

0 · Reply

NetworkNewsWire Jul. 29 at 6:32 PM

InvestorNewsBreaks – $VRXA Expands Patent Portfolio to Support Next-Generation Cancer Therapy Platforms https://ibn.fm/b5YiO

0 · Reply

AndorianMoons Jul. 29 at 12:47 PM

$VRXA https://investors.veraxa.com/news-releases/news-release-details/veraxa-biotech-strengthens-patent-portfolio-protect-core

0 · Reply

topstockalerts Jul. 27 at 8:08 PM

$VRXA low key strong… might catch people off guard

0 · Reply

NetworkNewsWire Jul. 27 at 3:47 PM

MissionIRNewsBreaks – $VRXA Shareholders Approve Corporate Governance, Financing Measures https://ibn.fm/PDGbt

0 · Reply

NetworkNewsWire Jul. 27 at 3:32 PM

BioMedNewsBreaks — $VRXA Advances Bispecific ADC Program Under OmniAb Collaboration https://ibn.fm/qMRuJ

0 · Reply

STKH Jul. 27 at 12:52 PM

$VRXA t 2

0 · Reply

JVB_1983 Jul. 27 at 11:21 AM

$VRXA

0 · Reply

AndorianMoons Jul. 26 at 1:41 AM

$VRXA https://investors.veraxa.com/news-releases/news-release-details/veraxa-biotech-shareholders-approve-all-proposals-extraordinary

0 · Reply

NetworkNewsWire Jul. 23 at 6:46 PM

NetworkNewsBreaks – $VRXA Appoints Christoph Erkel as Chief Scientific Officer https://ibn.fm/QH30X

0 · Reply

soutra Jul. 23 at 3:57 PM

$VRXA who else is down more than 5k ? ✋️ 🤚 🙋‍♂️

2 · Reply

aquira Jul. 23 at 1:58 PM

$VRXA are heading back to and lower than all time low? Disgusting fooken sheet

0 · Reply

Sanjaynaik2011 Jul. 22 at 11:32 PM

$VRXA ABSOLUTELY LOUSY AND DISGRACEFUL MANAGEMENT!! ONLY 81% DOWN SINCE LAUNCHED ABOUT A MONTH BACK!!! ONLY ONE WORD CAN DESCRIBE THIS COMPANY, DISGUSTING!!

0 · Reply

NetworkNewsWire Jul. 22 at 7:46 PM

$VRXA Advances BiTAC(R)-TCE Development with Positive Regulatory Feedback from Germany https://ibn.fm/y5u3k

0 · Reply

NetworkNewsWire Jul. 20 at 7:46 PM

MissionIRNewsBreaks – $VRXA Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform https://ibn.fm/M61PZ

0 · Reply

Innerchild Jul. 20 at 3:14 PM

$MTEN about to skyrocket ! $AMC $DGXX $VRXA $GOOG

0 · Reply

Innerchild Jul. 17 at 11:12 AM

$MTEN soon will rocket like never before! $VRXA $DGXX $CRMT $PHOE

0 · Reply

Innerchild Jul. 15 at 2:36 PM

$MTEN Don’t miss out on this, super early! 197$ is book value, super undervalued! $VRXA $PHOE $JTAI $NVVE

0 · Reply

Market Cap	59.14M
Revenue (ttm)	23,426.00
Net Income (ttm)	-66.61M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-284,359.22%
Debt to Equity Ratio	0.00

Volume	47,214
Avg Vol	N/A
Day's Range	N/A - N/A
Shares Out	31.63M
Stochastic %K	48%
Beta	0.26
Analysts	Strong Buy
Price Target	N/A